May 9, 20234BIO Capital Participates in $130M Funding of New Gene and Cell Manufacturing Specialist Ascend
Jun 8, 20224BIO Capital Portfolio Company Code Biotherapeutics Closes an Oversubscribed $75 Million Series A
Jun 6, 20224BIO Capital co-leads $30 million (¥3.86 Billion) oversubscribed Series B financing in LUCA Science